DrugPatentWatch Database Preview
Heparin sodium - Generic Drug Details
see a sample report or, see our see our flat-rate plans
What are the generic sources for heparin sodium and what is the scope of heparin sodium freedom to operate?
Heparin sodium
is the generic ingredient in thirty-eight branded drugs marketed by Hospira, Intl Medication, Luitpold, Parke Davis, Smith And Nephew, Solopak, Abraxis Pharm, Akorn, Casi Pharms Inc, Chamberlin Parenterl, Dell Labs, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira Inc, Lilly, Mylan Labs Ltd, Organon Usa Inc, Pfizer, Pharm Spec, Pharmacia And Upjohn, Sagent Pharms, Sandoz, Shenzhen Techdow, Watson Labs, Watson Labs Inc, West-ward Pharms Int, Baxter Hlthcare, Mcgaw, B Braun, Pharma Serve Ny, and 3M, and is included in seventy-seven NDAs. Additional information is available in the individual branded drug profile pages.There are seventy-seven drug master file entries for heparin sodium. Fifteen suppliers are listed for this compound.
Summary for heparin sodium
| US Patents: | 0 |
| Tradenames: | 38 |
| Applicants: | 31 |
| NDAs: | 77 |
| Drug Master File Entries: | 77 |
| Suppliers / Packagers: | 15 |
| Clinical Trials: | 66 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for heparin sodium |
| DailyMed Link: | heparin sodium at DailyMed |
Pharmacology for heparin sodium
| Ingredient-type | Heparin |
| Drug Class | Anti-coagulant Unfractionated Heparin |
US Patents and Regulatory Information for heparin sodium
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Labs Ltd | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 203852-001 | Nov 30, 2017 | AP | RX | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | |||
| Solopak | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 087077-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| 3m | LIPO-HEPIN | heparin sodium | INJECTABLE;INJECTION | 017027-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Watson Labs | HEPARIN SODIUM | heparin sodium | INJECTABLE;INJECTION | 017064-018 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Follow DrugPatentWatch: